Its ability to target multiple hormones involved in hunger and metabolism makes it a promising potential option
People who have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis should not go on GLP-1s, and neither should people with a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis
My experience, as well as current research, mirrors findings relayed in the 2001 Basel Thyroid Study
While patients often lose 13 pounds per week, the most refined transformations take months
Lotta LA, Pietzner M, Stewart ID, Wittemans LBL, Li C, Bonelli R, et al
Major side effects such as renal failure or blood poisoning may develop if a patient is given a dosage that is far higher than recommended